Health Catalyst director awarded 128,851 stock units

The award's vesting begins October 1, 2027, with the remaining units vesting in two equal annual installments.

Rhea-AI Filing Summary

Health Catalyst, Inc. director Tami Reller acquired an award of 128,851 restricted stock units on October 1, 2026. Each RSU represents a contingent right to receive one common share. The transaction table reports a direct post-transaction position of 128,851 shares; the footnote identifies the award as RSUs. Under the 2019 Plan and the Non-Employee Director Compensation Policy, 33.33% vest on October 1, 2027, and the remaining 66.67% vest in two equal annual installments.

Insider Trade Summary

Grant/Award: 128,851 shares

Grant/Award 1 txn

Insider Reller Tami

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	128,851	$0.00	$0.00

Holdings After Transaction: Common Stock — 128,851 shares (Direct)

Footnotes (1)

1. F1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on October 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.

Key Figures

Restricted stock units awarded: 128,851 RSUs Reported direct position after transaction: 128,851 shares First vesting portion: 33.33% +2 more

5 metrics

Restricted stock units awarded 128,851 RSUs Awarded October 1, 2026

Reported direct position after transaction 128,851 shares The footnote identifies the award as RSUs

First vesting portion 33.33% Vests October 1, 2027

Remaining vesting portion 66.67% Vests in two equal annual installments

Annual vesting installments 2 installments Applies to the remaining 66.67% of the RSUs

Key Terms

restricted stock units, 2019 Stock Option and Incentive Plan, contingent right, Non-Employee Director Compensation Policy

4 terms

restricted stock units financial

"award of the Issuer's restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2019 Stock Option and Incentive Plan financial

"granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan"

contingent right technical

"Each RSU represents a contingent right to receive one share"

Non-Employee Director Compensation Policy financial

"in accordance with the terms of Issuer's Non-Employee Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did HCAT director Tami Reller receive?

Health Catalyst director Tami Reller received 128,851 restricted stock units on October 1, 2026. Each RSU represents a contingent right to receive one common share; 33.33% vest on October 1, 2027, and the remaining 66.67% vest in two equal annual installments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:01 PM Accepted by SEC EDGAR 10/05/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reller Tami

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A		128,851(1)	A	$0.00	128,851	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on October 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)